Pediatrix Q3 EPS $0.84, revenue $493M; raises FY2025 Adj. EBITDA outlook to $270-290M

Pediatrix Medical Group, Inc.

2025-Q3 EPS reported $1.54 revenue$1,420,078,000

Net income $71.7M ($0.84/share) vs $19.4M ($0.23) year ago; adjusted EPS $0.67 vs $0.44.
Net revenue $492.9M, down 3.6% YoY; same-unit net revenue rose 8.0%.
Adjusted EBITDA $87.3M vs $60.2M; guidance raised to $270-290M from prior range.
Same-unit volume growth of 0.4%; NICU days up 2.2% and reimbursement factors up 7.6%.
Used $20.9M for share repurchases, $19.2M for acquisitions in Q3.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.